NCT02931136View on ClinicalTrials.gov

Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Mild Cognitive ImpairmentBiomarkerDiagnosisTreatment
Interventions
DRUG

Huperzine A

The participants will treatment by the Huperzine A 200 ug/day in 52 weeks.

DRUG

Placebo

The participants will treatment by the placebo in 52 weeks.

Trial Locations (1)

200030

Shanghai Mental Health Center, Shanghai

All Listed Sponsors
lead

Shanghai Mental Health Center

OTHER